Our Mission

We focus on equity investments in young biotech companies possessing pioneering technologies and competencies that hold the potential to influence the future of the pharmaceutical industry.

In following our aim,

• We base our activities on the scientific, technological and commercial competencies available within Novo Nordisk
• We provide the opportunity for the talented entrepreneur to benefit from these resources available at Novo Nordisk
• We are dedicated to adding value to our investment partners through dialogue with their management team, thereby providing value towards a successful and fast commercialisation and maturation.